How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless Disease.

Galvez-Llompart, Maria; Zanni, Riccardo; Garcia-Domenech, Ramon; Galvez, Jorge

Galvez-Llompart, Maria; Zanni, Riccardo; Garcia-Domenech, Ramon; Galvez, Jorge.

Afiliação

Galvez-Llompart M; Instituto de Tecnología Química, UPV-CSIC, Universidad Politécnica de Valencia, 46022 Valencia, Spain.
Zanni R; Molecular Topology and Drug Design Unit, Department of Physical Chemistry, University of Valencia, 46100 Valencia, Spain.
Garcia-Domenech R; Molecular Topology and Drug Design Unit, Department of Physical Chemistry, University of Valencia, 46100 Valencia, Spain.
Galvez J; Molecular Topology and Drug Design Unit, Department of Physical Chemistry, University of Valencia, 46100 Valencia, Spain.

Pharmaceuticals (Basel) ; 15(1)2022 Jan 14.

Article em En | MEDLINE | ID: mdl-35056151

Palavras-chave

QSAR; amyotrophic lateral sclerosis; drug design; drug repurposing; molecular topology; orphan diseases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google